Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas

scientific article published in January 1982

Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00296754
P698PubMed publication ID6890414

P2093author name stringA Smith
N Thatcher
R Harrison
H Sharma
D Crowther
A Zaki
B W Fox
C A McAuliffe
P2860cites workThe Role of cis-Platinum in Solid-Tumor TherapyQ39783487
Cisplatin (cis-diamminedichloroplatinum II)Q39798603
Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresisQ41442106
Kinetics of cis-dichlorodiammineplatinumQ67467904
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II)Q69025482
Cisplatin disposition in children and adolescents with cancerQ70667286
Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionQ72626640
P433issue1
P921main subjectplatinumQ880
P304page(s)13-16
P577publication date1982-01-01
P1433published inCancer Chemotherapy and PharmacologyQ326137
P1476titleBlood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas
P478volume9

Reverse relations

cites work (P2860)
Q71228883A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)
Q38478125A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
Q78179609Absorbed doses to patients from 191Pt-, 193mPt- and 195mPt-cisplatin
Q53559996Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.
Q68539274Experimental studies of chemosensitivity testing of urothelial cancer grown in nude mice
Q51608886In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobu
Q36375326Mass balance studies, with a focus on anticancer drugs.
Q51608773Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
Q53923481Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.
Q51608850Primary carcinoma of the fallopian tube: favourable response to new chemotherapeutic agent, CHIP.
Q73232674The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent

Search more.